In the pursuit of peak physical performance, body recomposition, and strength optimization, the landscape of performance-enhancing compounds is constantly evolving. Among the most sophisticated and highly-researched agents to emerge in recent years is RAD140, known commonly as Testolone. GenLabs, a name synonymous with pharmaceutical-grade purity and scientific integrity, is proud to present TESTOLONE RAD140 20mg / per capsule – 30 capsules, a premium formulation designed for the discerning researcher seeking the potent, selective benefits of this revolutionary SARM.
This description serves as an in-depth, educational resource on RAD140, detailing its unique mechanism of action, potential research applications, and the unparalleled quality assurance of the GenLabs brand. We prioritize scientific transparency and provide this information for educational and research purposes only.
RAD140 (Testolone) is a non-steroidal, investigational Selective Androgen Receptor Modulator (SARM). Its development represents a significant leap forward from traditional anabolic agents. To appreciate its potential, one must understand its core principle: selectivity.
Traditional anabolic-androgenic steroids (AAS) bind to androgen receptors throughout the body, including muscle, bone, brain, skin, and prostate. This systemic activation leads to both desired anabolic effects (muscle growth) and unwanted androgenic side effects (e.g., hair loss, prostate enlargement, hormonal axis suppression).
RAD140 is engineered differently. It exhibits a high affinity for androgen receptors specifically in muscle and bone tissue, while demonstrating markedly lower activity in prostate and skin cells. This targeted approach is the foundation of its promise—aiming to deliver potent anabolic outcomes with a potentially reduced side effect profile compared to classical steroids.
The potency of RAD140 stems from its robust binding to the androgen receptor (AR) and its subsequent actions:
Full Agonist Activity in Muscle & Bone: In target tissues, RAD140 binds strongly to the AR, initiating a cascade of gene transcription events that promote protein synthesis, nitrogen retention, and increased metabolic activity. This leads to accelerated muscle tissue growth and enhanced bone density.
Tissue-Selective Modulation: Its chemical structure allows it to recruit specific co-activators and co-repressors in different tissues. In muscle, it promotes strong anabolic signaling. Evidence suggests it may act as a partial agonist or even antagonist in other tissues, thereby mitigating androgenic effects.
Neuroprotective Properties: Notably, RAD140 has shown investigational promise as a neuroprotective agent in preclinical studies, binding to ARs in neural tissues. This unique property distinguishes it from many other performance-focused compounds and is a key area of scientific interest.
Anabolic to Androgenic Ratio: Preliminary research indicates RAD140 may possess a significantly higher anabolic-to-androgenic ratio than testosterone, potentially as high as 90:1. This theoretical ratio underscores its design as a muscle-selective agent.
In a research context, RAD140 is studied for its profound impact on body composition and strength. Its profile is characterized by:
Rapid, Quality Muscle Accretion: Promotes lean, dense muscle mass gains with a notable absence of excessive water retention, leading to a "harder," more defined physique.
Exceptional Strength Increases: Users often report dramatic and rapid improvements in strength output, leverage, and training capacity, facilitating more intense and productive research models.
Enhanced Fat Loss & Metabolic Rate: Through increased muscle mass and direct metabolic effects, RAD140 may support a significant reduction in adipose tissue, making it a compelling agent for body recomposition studies (simultaneous fat loss and muscle gain).
Improved Bone Density & Joint Integrity: Its activity on bone tissue can contribute to enhanced mineral density and improved joint resilience under load.
Increased Endurance and Recovery: By optimizing the body's anabolic environment, research subjects may experience reduced fatigue and accelerated recovery between research sessions.
The market is saturated with under-dosed, impure, and mislabeled SARM products. GenLabs eliminates this uncertainty with an uncompromising commitment to quality.
Pharmaceutical-Grade Raw Materials: Every batch of RAD140 is sourced from premier, certified laboratories, ensuring 99%+ chemical purity.
Precise 20mg Dosage: Each capsule contains an exact, verified 20mg of RAD140. No under-dosing, no fillers masquerading as the active compound.
Third-Party Laboratory Verification: Our products are not just "claimed" to be pure; they are independently tested by accredited third-party laboratories. Batch-specific Certificates of Analysis (CoA) are available, confirming identity, purity, and concentration.
cGMP Manufacturing: Production occurs in certified facilities following current Good Manufacturing Practices (cGMP), guaranteeing hygiene, consistency, and procedural excellence.
Encapsulated for Stability & Accuracy: The capsule form ensures accurate dosing, protects the compound from degradation, and simplifies handling compared to liquid research solutions.
Dosage & Cycle Length: In research models, RAD140 is typically studied at doses ranging from 10mg to 30mg daily. The 20mg per capsule dosage offered by GenLabs sits firmly in the effective mid-to-upper range, ideal for experienced researchers. Common investigatory cycles last 8-12 weeks, allowing sufficient time to observe its full effects.
Post-Cycle Therapy (PCT) Considerations: As a potent SARM, RAD140 can suppress endogenous testosterone production in research subjects. The degree is dose and duration-dependent. Responsible research planning includes provisions for a Post-Cycle Therapy (PCT) protocol to help restore natural hormonal homeostasis after the conclusion of the study. This typically involves agents like SERMs (e.g., Tamoxifen, Enclomiphene) and should be planned in advance.
Side Effect Profile (Research Observations): While designed for selectivity, potential research observations at higher doses or extended durations may include mild suppression of HDL ("good") cholesterol, transient changes in liver enzymes (though considered less hepatotoxic than many oral steroids), and, of course, testosterone suppression. These underscore the need for controlled, monitored research.
Choosing GenLabs TESTOLONE RAD140 is more than a purchase; it's an investment in reliable, high-fidelity research materials. We empower scientists, biohackers, and advanced performance researchers with the tools they need to conduct meaningful, reproducible studies.
Product Specifications:
Compound: RAD140 (Testolone)
Concentration: 20mg per capsule
Quantity: 30 capsules
Form: Pharmaceutical-grade powder in vegetarian capsules
Purity: ≥99% (Third-party verified)
Manufacturer: GenLabs
Disclaimer: This product is intended for laboratory and research purposes only, in vitro studies, or for use in animal studies under the direct supervision of a qualified professional. It is not for human consumption. It is not a dietary supplement, nor is it intended to diagnose, treat, cure, or prevent any disease. Keep out of reach of children and unauthorized personnel. Researchers are responsible for complying with all local, state, and federal laws regarding the possession and use of research chemicals.
On all orders is set at $25.00
Protected by Bitcoin
On all huge orders